Abstract:Haidong Cheng, 1, * Gaowa Sharen, 2, * Zhaoyang Wang, 1 Jing Zhou 3 1 Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China; 2 Department of Pathological Anatomy, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China; 3 Department of Pharmacology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China *These authors contributed equally to this work Correspondence: Zhaoyang Wang Department of Gastroenterology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China Email wzydoc@126.com Jing Zhou Department of Pharmacology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot 010059, People's Republic of China Email 591716788@qq.com Background: Chemoresistance contributes to treatment failure of gastric cancer (GC) patients but the molecular mechanism of chemoresistance in GC is still unclear. Long-chain noncoding RNA (lncRNA) urothelial cancer associated 1 ( UCA1 ) is associated with resistance to chemotherapy drugs. Methods: We detected the expression of UCA1 in 53 pairs of GC tumor tissue and adjacent normal tissue, human normal gastric mucosa cells (GES-1) and human GC cells (HGC-27, SNU-5, AGS, SGC-7901, and NCI-N87) using RT-qPCR. Small RNA interference technology was used to knock down the expression of UCA1 in gastric cancer cells. CCK8 solution was used to detect cell viability. Flow cytometry was used to detect apoptosis, and Western blotting was used to detect protein expression. Results: UCA1 was highly expressed in GC tissues and cells, and knockdown of UCA1 increased chemosensitivity to cisplatin by inducing cell apoptosis. Furthermore, UCA1 promoted CYP1B1 expression by binding to miR-513a-3p in human GC cells in vitro, and UCA1 / CYP1B1 expression was negatively related to miR-513a-3p expression, while UCA1 expression was positively related to CYP1B1 expression in human GC tissues. Moreover, overexpression of miR-513a-3p or knockdown of CYP1B1 increased chemosensitivity to cisplatin, and knockdown of miR-513a-3p or overexpression of CYP1B1 decreased chemosensitivity to cisplatin by inducing cell apoptosis in human GC cells. Importantly, overexpression of CYP1B1 reduced chemosensitivity to cisplatin which increased by knockdown of UCA1 , and knockdown of CYP1B1 increased chemosensitivity to cisplatin which decreased by knockdown of miR-513a-3p in human GC cells. Conclusion: The lncRNA UCA1 / miR-513a-3p / CYP1B1 axis regulates cisplatin resistance in human GC cells; hence, it is a potential target for treating chemoresistance in GC. Keywords: gastric cancer, urothelial cancer associated 1, chemoresistance

Long non-coding RNA UCA1 Knockdown Assisted by CRISPR/Cas9 in Female Cancer Cell Lines Increases Mir-143 Tumor-Suppressor

Long Non-Coding RNA UCA1 Regulates SRPK1 Expression Through Mir-99B-3p in Ovarian Cancer.

Long Noncoding RNA UCA1 Promotes Cell Growth, Migration, and Invasion by Targeting Mir‐143‐3p in Oral Squamous Cell Carcinoma

Downregulation of Long Non-Coding RNA MR4435-2HG Suppresses Breast Cancer Progression Via the Wnt/β-catenin Signaling Pathway.

Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer

Long Non-Coding RNA UCA1 Promotes Lung Cancer Cell Proliferation and Migration Via Microrna-193A/hmgb1 Axis.

Long Non-Coding RNA UCA1 Regulates the Proliferation, Migration and Invasion of Human Lung Cancer Cells by Modulating the Expression of Microrna-143

Suppression of Long Non-Coding RNA UCA1 Inhibits Proliferation and Invasion and Induces Apoptosis in Human Lung Cancer Cells.

Lncrna Uca1 In Anti-Cancer Drug Resistance

Long Non-Coding Rna Uca1 Induces Non-T790m Acquired Resistance to Egfr-Tkis by Activating the Akt/Mtor Pathway in Egfr-Mutant Non-Small Cell Lung Cancer

Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout.

UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging Mir-135A.

LncRNA-UCA1 Enhances Cell Proliferation and 5-Fluorouracil Resistance in Colorectal Cancer by Inhibiting Mir-204-5p.

lncRNA UCA1 Increases Proliferation and Multidrug Resistance of Retinoblastoma Cells Through Downregulating miR-513a-5p

Lncrna UCA1 Mediates Resistance to Cisplatin by Regulating the Mir-143/Fosl2-signaling Pathway in Ovarian Cancer.

IMP1 Regulates UCA1-mediated Cell Invasion Through Facilitating UCA1 Decay and Decreasing the Sponge Effect of UCA1 for Mir-122-5p.

Hsa-miR-1 Downregulates Long Non-Coding RNA Urothelial Cancer Associated 1 in Bladder Cancer.

Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1.

LncRNA UCA1 Enhances Cisplatin Resistance by Regulating CYP1B1-mediated Apoptosis via miR-513a-3p in Human Gastric Cancer

Long Non-Coding RNA Urothelial Carcinoma Associated 1 Promotes Proliferation, Migration and Invasion of Osteosarcoma Cells by Regulating Microrna-182.

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma